[Continuous glucose monitoring data: how can they be collected and used in practice?] / Les données de la mesure continue du glucose : comment les récupérer et pour quel usage dans la pratique ?
Rev Prat
; 74(3): S13-S17, 2024 Mar.
Article
en Fr
| MEDLINE
| ID: mdl-38551885
ABSTRACT
CONTINUOUS GLUCOSE MONITORING DATA HOW CAN THEY BE COLLECTED AND USED IN PRACTICE? Continuous glucose monitoring (CGM) is becoming an essential part of diabetes management. The AGP report is obtained over a 14-day period, with at least 70% of captured data. The time spent in the 70-180 mg/dl targel range, withe a target of over 70% or 50% in frail patients, is a new parameter that is essential for assessing glycemic control via CGM. Complemented by estimated HBA1c, now called GMI (Glucose Management Indicator), the time spent in hypoglycemia (target inférieur 5% or even inférieur 1% for frail patients) and the coefficient of variation (target inférieur 36%), the CGM offers a very comprehensive analysis of blood glucose levels, with individualized treatment adjustments based on ambulatory blood glucose profiles.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Diabetes Mellitus Tipo 1
/
Hipoglucemia
Límite:
Humans
Idioma:
Fr
Revista:
Rev Prat
Año:
2024
Tipo del documento:
Article
País de afiliación:
Francia